Federal Schedule III Rescheduling and DEA Registrations
Key Questions
What is the scope of the DEA's Schedule III rescheduling order for cannabis?
The DEA's narrow order applies only to FDA-approved products and state-licensed medical marijuana. It opens a registration window for qualifying entities while imposing SOP and ownership requirements. The status of these changes remains developing.
How does the rescheduling order affect tax relief for cannabis dispensaries?
The DOJ order enables 280E tax relief for dispensaries without requiring a full shift to recreational cannabis. This change alters the tax landscape for medical marijuana businesses following the DEA's final order. Potential national pesticide standards may also emerge as part of broader regulatory developments.
What registration requirements apply to entities under the new Schedule III framework?
DEA registration requires compliance with standard operating procedures (SOP) and specific ownership rules for approved medical cannabis operations. The process is limited to FDA-approved products and state-licensed programs. Related proposals from agencies like the ATF are also under consideration following rescheduling.
DEA narrow Schedule III order applies only to FDA-approved products and state-licensed medical marijuana, opening registration window with SOP/ownership requirements; DOJ order enables 280E tax relief for dispensaries without full recreational change. Potential national pesticide standards emerging. Status remains developing.